Economic Burden of Switching to Different Biologic Therapies Among Tumor Necrosis Factor Inhibitor-Experienced Patients with Psoriatic Arthritis
Crossref DOI link: https://doi.org/10.1007/s40744-019-0158-2
Published Online: 2019-05-04
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Song, Yan https://orcid.org/0000-0002-7566-2813
Betts, Keith A.
Lu, Yichen
Singh, Rakesh
Clewell, Jerry
Griffith, Jenny
Funding for this research was provided by:
AbbVie Biotherapeutics
Text and Data Mining valid from 2019-05-04
Version of Record valid from 2019-05-04
Article History
Received: 7 March 2019
First Online: 4 May 2019